ConductScience.org, home

Paper2775615

The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa.

Robertson DR and 6 others. Br J Clin Pharmacol, 1989. Cited by 85 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa. Papers, record 2775615. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2775615

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1989
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
85
iCite
Relative citation ratio, by iCite
4.12
iCite
Revised in PubMed
2022-04-09
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Robertson DRD R
2Wood NDN D
3Everest HH
4Monks KK
5Waller DGD G
6Renwick AGA G
7George CFC F

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AgingMajor topic
CarbidopaMajor topic
LevodopaMajor topic
Administration, Oral
Adult
Aged
Drug Interactions
Female
Humans
Injections, Intravenous
Male

Source PubMed

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16,052,883The assessment of the amount of fat in the human body from measurements of skinfold thickness.Br J Nutr1967https://conductscience.org/library/papers/6052883PubMed
214,270,624THE EFFECT OF INCREASING AGE ON THE DISTRIBUTION OF PERIPHERAL BLOOD FLOW IN MAN.J Am Geriatr Soc1965https://conductscience.org/library/papers/14270624PubMed
35,459,997Adult lean body mass declines with age: some longitudinal observations.Metabolism1970https://conductscience.org/library/papers/5459997PubMed
45,100,498Incidence of side effects from levodopa during the introduction of treatment.Br Med J1971https://conductscience.org/library/papers/5100498PubMed
55,171,067Absorption and metabolism of levodopa.JAMA1971https://conductscience.org/library/papers/5171067PubMed
65,061,285Catecholamine metabolism during oral administration of levodopa.Arch Neurol1972https://conductscience.org/library/papers/5061285PubMed
74,686,016Effects of L-dopa administration of the concentrations of dopa, dopamine and norepinephrine in various rat tissues.J Pharmacol Exp Ther1973https://conductscience.org/library/papers/4686016PubMed
84,702,182Levodopa for parkinsonism in elderly and demented patients.Med J Aust1973https://conductscience.org/library/papers/4702182PubMed
94,528,851Variability of L-dopa absorption in man.Aust N Z J Med1974https://conductscience.org/library/papers/4528851PubMed
104,418,704Effects of levodopa therapy in patients with Parkinson's disease: statistical evidence for reduced tolerance to levodopa in the elderly.J Am Geriatr Soc1974https://conductscience.org/library/papers/4418704PubMed
111,123,640Fluctuations in DOPA decarboxylase activity with age.J Neurochem1975https://conductscience.org/library/papers/1123640PubMed
121,164,821Commentary: a physiological approach to hepatic drug clearance.Clin Pharmacol Ther1975https://conductscience.org/library/papers/1164821PubMed
13782,834Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.Drugs1976https://conductscience.org/library/papers/782834PubMed
14759,567Brain tissue and plasma assay of L-DOPA and alpha-methyldopa metabolites by high performance liquid chromatography with electrochemical detection.J Neurochem1979https://conductscience.org/library/papers/759567PubMed
15391,463Drug kinetics and hepatic blood flow.Clin Pharmacokinet1979https://conductscience.org/library/papers/391463PubMed
167,363,934Systemic activity of orally administered L-dopa in the elderly Parkinson patient.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/7363934PubMed
177,246,340Senile parkinsonism, a study of current treatment.Age Ageing1981https://conductscience.org/library/papers/7246340PubMed
187,264,915Dosage form design for improvement of bioavailability of levodopa IV: Possible causes of low bioavailability of oral levodopa in dogs.J Pharm Sci1981https://conductscience.org/library/papers/7264915PubMed
197,202,139Gastric emptying rate and the systemic availability of levodopa in the elderly parkinsonian patient.Neurology1981https://conductscience.org/library/papers/7202139PubMed
206,660,139Diagnosis and management of parkinsonism in the elderly.Age Ageing1983https://conductscience.org/library/papers/6660139PubMed

See all 27 references

Cited by44

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 85 citations.

PMIDTitleJournalYearIn PapersSource
41,172,985Bioengineered gut bacterium synthesizing levodopa alleviates motor deficits in models of Parkinson's disease.Cell Host Microbe2025https://conductscience.org/library/papers/41172985PubMed
40,483,284Development of an in-situ forming implant system for levodopa and carbidopa for the treatment of parkinson's disease.Drug Deliv Transl Res2025https://conductscience.org/library/papers/40483284PubMed
40,464,628The Treatment of Older Patients with Parkinson's Disease.Dtsch Arztebl Int2025https://conductscience.org/library/papers/40464628PubMed
38,905,055Impact of Physical Exercise on Levodopa Therapy Across Parkinson's Disease Stages.J Parkinsons Dis2024https://conductscience.org/library/papers/38905055PubMed
36,309,950Effect of Carbidopa Dose on Levodopa Pharmacokinetics With and Without Catechol-O-Methyltransferase Inhibition in Healthy Subjects.Eur J Drug Metab Pharmacokinet2023https://conductscience.org/library/papers/36309950PubMed
35,541,045Simultaneous electrochemical determination of levodopa and piroxicam using a glassy carbon electrode modified with a ZnO-Pd/CNT nanocomposite.RSC Adv2018https://conductscience.org/library/papers/35541045PubMed
32,477,245Dopamine Buffering Capacity Imaging: A Pharmacodynamic fMRI Method for Staging Parkinson Disease.Front Neurol2020https://conductscience.org/library/papers/32477245PubMed
31,781,365Patterns and Determinants of Prescribing for Parkinson's Disease: A Systematic Literature Review.Parkinsons Dis2019https://conductscience.org/library/papers/31781365PubMed
31,681,153Contributions of Gut Bacteria and Diet to Drug Pharmacokinetics in the Treatment of Parkinson's Disease.Front Neurol2019https://conductscience.org/library/papers/31681153PubMed
31,258,882Pharmacokinetics and tolerability of inhaled levodopa from a new dry-powder inhaler in patients with Parkinson's disease.Ther Adv Chronic Dis2019https://conductscience.org/library/papers/31258882PubMed
30,847,947Vasodilation through levodopa for Parkinson's disease may require high left ventricular assist device flow.J Card Surg2019https://conductscience.org/library/papers/30847947PubMed
28,236,251Pharmacokinetics of Rytary®, An Extended-Release Capsule Formulation of Carbidopa-Levodopa.Clin Pharmacokinet2017https://conductscience.org/library/papers/28236251PubMed
28,101,657Levodopa/carbidopa microtablets in Parkinson's disease: a study of pharmacokinetics and blinded motor assessment.Eur J Clin Pharmacol2017https://conductscience.org/library/papers/28101657PubMed
27,247,848Causes and factors related to dopamine agonist withdrawal in Parkinson's disease.Brain Behav2016https://conductscience.org/library/papers/27247848PubMed
26,779,024The Human Experience with Intravenous Levodopa.Front Pharmacol2015https://conductscience.org/library/papers/26779024PubMed
26,336,641Orthostatic stability with intravenous levodopa.PeerJ2015https://conductscience.org/library/papers/26336641PubMed
25,838,754Effects of Parkinson's Disease on Fundamental Frequency Variability in Running Speech.J Med Speech Lang Pathol2013https://conductscience.org/library/papers/25838754PubMed
25,413,723Empirical and semi-mechanistic modelling of double-peaked pharmacokinetic profile phenomenon due to gastric emptying.AAPS J2015https://conductscience.org/library/papers/25413723PubMed
24,631,952Preventive effect of rikkunshito on gastric motor function inhibited by L-dopa in rats.Peptides2014https://conductscience.org/library/papers/24631952PubMed
24,433,449Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusion vs. oral tablets.Br J Clin Pharmacol2014https://conductscience.org/library/papers/24433449PubMed

See all 44 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2775615

GET https://conductscience.org/api/papers/v1/2775615/references?page=2